8 November 2022FeaturesMuireann Bolger

Sea change: a Q&A with Kathi Vidal

You have always been a proponent of diversity and inclusion. What drove you to make that an area of focus?

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Atif Choudhury at achoudhury@lifesciencesipreview.com

More on this story

Careers

K&L Gates expands European practice with Munich team hire

5 August 2026 Strategic addition marks the latest investment in the firm’s European platform as demand for cross-border patent expertise continues to grow.

MedTech

Insulet asks Fed Circ to rehear $59.4m trade secret reversal

3 August 2026 The medical device maker says that a split appellate decision raises broader questions about trade secret law, jurisdiction and when the clock starts ticking on misappropriation claims.

Careers

Arnold & Porter adds firepower to ITC practice with new partner hire

3 August 2026 Appointment strengthens the firm’s expertise in US International Trade Commission proceedings and cross-border intellectual property disputes.

More features

USPTO director steps into Sun Pharma’s PTAB-ITC clash

USPTO appoints new acting commissioner for patents

Pharmascience v Janssen: Canada court updates methods of medical treatment protection

Exclusive: ‘Cultural differences are an asset’ at the UPC

WATCH: AI-powered patent prosecution for life sciences innovation

WATCH: Overcoming patent eligibility, patentability, and disclosure requirements in life sciences innovation

Five generations at work: How teams are bridging the gap

Squires refuses to resurrect HydraFacial patent review

Sea change: a Q&A with Kathi Vidal

More on this story

Editor's picks

Editor's picks

More features